Daptomycin is a 13-residue cyclic lipopeptide with Ca 2ϩ -dependent bactericidal activity against a variety of high-risk pathogens. Ring closure in daptomycin is via an ester linkage between the side chain of-free daptomycin is reported to lack a well-defined conformation (D. Jung, A. Rozek, M. Okron, and R. E. W. Hancock, Chemistry & Biology, 2004, Vol. 11, pp. 949-957) or is suggested to populate an alternate conformation (L.-J. Ball, C. M. Goult, J. A. Donarski, J. Micklefield, and V. Ramesh, Organic & Biomolecular Chemistry, 2004, Vol. 2, pp. 1872-1878 Contract grant sponsor: CUBIST Pharmaceuticals and NIH Contract grant number: GM27616 (NIH) *We dedicate this article to the memory of Murray Goodman, a bigger-than-life peptide chemist. He pursued the science of peptide design and synthesis, structure determination, and biological activity with passion. He showed by example how warmth and scientific zeal are contagious traits that engender international liaisons in the pursuit of common goals. He will be sorely missed.